Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Monopar Therapeutics Inc. of our report dated March 27, 2026, relating to the consolidated financial statements, which appears in Monopar Therapeutics Inc.’s Annual Report on Form 10-K for the year ended December 31, 2025.

 

/s/ BPM LLP

Santa Rosa, California

July 22, 2026